Skip to content

We will be at DCAT Week 2026!

23-26th March 2026 in NYC

Upcoming tradeshows and conferences 

PDA

Oct 21 - Oct 22, 2025
Vienna, Austria
Hall X2, #150

PODD

Oct 27 -Oct 29, 2025
Boston, MA, USA
#26

CPHI

Oct 28 - Oct 30, 2025
Frankfurt, Germany
Hall 8, #0J92

Don’t miss our presentations at PODD and CPHI!

  • PODD
    • Monday, October 27, 2025 – 05:30 PM - 05:45 PM
      A Novel Approach to Modelling Injector Performance and Break-Loose Extrusion Force Data
      Presenter: Tom Oakley, Springboard, co-presenting with Deep Bhattacharya, Pfizer
  • CPHI
    • Wednesday, October 29, 2025 – 11:35 AM - 12:05 PM
      Rethinking Injector Mechanics – A New Approach to BLEF-Based Modelling
      Speakers: Tom Oakley, Springboard, co-presenting with Jay Sayed, Pfizer
    • Wednesday, October 29, 2025 – 12:05 PM - 12:20 PM
      Modelling to Market – Enabling Smarter, Faster Injector Development
      Speaker: Alex Vasiev, Springboard

Meet our experts at the conferences

Feel free to reach out to our sales representatives to arrange a meeting in advance.
Click on the images to send an email.

Christian Classen-1

Christian Classen
Chief Sales Officer, CSO
PDA, CPHI

Tom Oakley

Tom Oakley
VP Strategic Design & Development Partnerships (Europe)
PODD, CPHI

01-geoff-jones2

Geoff Jones
Vice President Sales, CDMO
PDA, CPHI

Ed Butler

Ed Butler
Business Development Manager
PDA, PODD

03-chuck-crandley

Chuck Crandley
Business Development Manager
PODD

Sven Dasbach

Sven Dasbach
Business Development Manager
CPHI

Paula Dominguez

Paula Domínguez
Business Development Manager
CPHI

Joe Masci

Joe Masci
Business Development Manager
PODD

Cameron Palagruto

Cameron Palagruto
Business Development Manager
PODD

Alex Vasiev

Alex Vasiev
Business Development Manager
CPHI

  

We are happy to welcome you at our DCAT Suite
in the Lotte NY Palace #2002.

Come meet us at New York City’s flagship annual business development event for global pharmaceutical manufacturing companies and find out how we can support you throughout your entire development and manufacturing value chain.

Stefan Verheyden

Stefan Verheyden
CEO
S.Verheyden@sanner-group.com

Christian Classen

Christian Classen 
CSO
C.Classen@sanner-group.com

Ted Mosler

Ted Mosler 
CTO
tmosler@gilero.com

Geoff Jones

Geoff Jones
VP Sales, CDMO – Europe & North America
g.jones@sanner-group.com

Chuck Crandley

Chuck Crandley
Associate VP Sales, CDMO
ccrandley@gilero.com

Sanner Group - Who we are

 

Bild (2)  Our Vision

Protecting Health.

Bild (4)  Our Mission

To partner with healthcare companies to develop and manufacture products globally.

Bild (3) Our values

  • Reliable
  • Agile
  • Collaborative
  • Transparent
  • Sustainable
Sanner-Group-Ecovadis-Gold-2025

How we operate

 

We operate with substantial production capacity, agility and scalability that enable us to support companies to bring medical devices to market efficiently and effectively.

 

 

Learn more about Sanner Group here:

 

 

 

How we operate

The value we add to you

As a CDMO, we provide a full spectrum of services, from the initial design and development phases to mass production of everything from simple, single-use consumables to complex electromechanical devices.

With more than 60 years of experience in providing physical and chemical stability packaging for moisture sensitive drug products, we offer desiccant solutions for medical and diagnostic devices.

Our agility, scalability and substantial production capacity allows us to cater to a wide range of specific customer needs—whether for small production runs or high-volume manufacturing.

Supported by our state-of-the-art production facilities across Europe, Asia, and North America, Sanner is a strong partner of choice to support our clients to bring medical devices to their local markets efficiently.

What makes the difference

“At Sanner, we turn complex device ideas into scalable solutions.”

With a pool of 150 specialized engineers, we assemble exactly the right team for your development challenge.

Our global footprint across three continents seamlessly connects development and manufacturing—reducing risk and accelerating time to market.

And as an agile, customer-focused partner, we bring available capacity, fast decision-making, and a solution-oriented mindset to move your project forward.

We offer worldwide production capacity and device development services

Sanner operates a global manufacturing network with a total production space of 28,500 sqm, including 11,000 sqm of cleanroom space (Class 7/8). Our Design Centers of Excellence, Springboard and Gilero, are strategically located in the UK and across the US. Our manufacturing facilities are based in the US, Asia and Europe.

Sanner locations

How we can support you as a global medical device CDMO

  • Capacity for small-batch prototypes and scaling to full production. Our facilities are equipped to handle a wide range of production needs:
    • High precision fully electric thermoplastic injection molding capable of handling small shot weights (around 0.1g) up to 64-cavity molds (max. 350T), including multi-K molding with thermoplastic elastomers (TPE). 
    • Manual assembly up to fully automated assembly processes, incorporating mechatronic components for enhanced efficiency and precision.
    • End of line packaging for sub-assemblies or finished goods
    • Sterilization through trusted external partners, utilizing validated processes to ensure compliance with industry standards.
  • Our experience in successfully transferring innovations to production across the EU, US, and China speaks to our ability to bring cutting-edge technologies to global markets. All phases of device development can be supported from our Design and Development Centers of Excellence in both the US and EU. 
  • Our design transfer processes enable the smoother path to market. We offer end-to-end thinking from development to manufacturing all under one roof to de-risk your project and for a better time to market.
  • Our reliability and collaborative working attitude support you in any stage of your project.

 

Quality control processes and compliance with ISO 13485

Sanner Group facilities are ISO 13485 certified for Design & Development and Manufacturing respectively. Over 250 ISO, AAMI/ANSI standards are used routinely. Our streamlined quality system satisfies the FDA requirements for both the device quality system regulations and the part 210/211 cGMP regulations.

 

Talk to an expert!
We are happy to support your device development project!